This is the same basic threshold used for GLP-1 weight loss medications
Frosst P, Blom HJ, Milos R, Goyette P, Sheppard CA, Matthews RG, Boers GJH, den Heijer M, Kluijtmans LAJ, van den Heuvel LP, and Rozen R (1995)
Manufactured in a facility that processes products containing milk, soy, eggs, gluten, nuts, peanuts, fish, shellfish, and sesame
whether the same adverse event profile applies to subcutaneous administration of research chemicals at community-discussed doses is unknown
Use COA and batch records to support identity review
This approach uses smaller amounts distributed across the week, which some patients find reduces nausea and side effects while still providing consistent appetite control